Pulmonary alveolar proteinosis in infants

Y Sakai, W Abo, H Yoshimura, H Sano, Y Kuroki… - European journal of …, 1999 - Springer
We investigated the histological and molecular characteristics of pulmonary alveolar
proteinosis (PAP) in two siblings (a brother and sister) who did not exhibit respiratory …

[图书][B] Processing, stability and interactions of lung surfactant protein C

J Li - 2005 - openarchive.ki.se
Mature SP-C is a 4.2 kDa transmembrane protein which is uniquely expressed in the
alveolar type II cell. Human SP-C is generated via multistep proteolytic cleavage of both the …

The effect of nasal continuous positive airway pressure after administration of surfactant on less than 32 week old preterm newborns with respiratory distress …

M Heidarzadeh, A Safaralizadeh… - Journal of Arak …, 2010 - jams.arakmu.ac.ir
Background: Among respiratory support techniques, nasal continuous positive airway
pressure (NCPAP) and mechanical ventilation (MV) are more known for their effectivity in …

Pulmonary surfactant and biophysical function

R Herold, R Dewitz, S Schürch, U Pison - Studies in Interface Science, 1998 - Elsevier
Publisher Summary This chapter outlines current knowledge on pulmonary surface and
surfactant investigations and targets at modelling of the surface-related interactions between …

Interstitial lung disease in children

R Dinwiddie, O Crawford, N Sharief - Diffuse Lung Disorders: A …, 1999 - Springer
Interstitial lung disease in children is uncommon. It usually presents with the gradual onset
of increasing respiratory symptoms including tachypnoea, effort dyspnoea and cyanosis. In …

The molecular basis of pulmonary surfactant–lessons from newborn infants

JA Whitsett - Hamdan Medical Journal, 2012 - journals.lww.com
Major scientific advances in prenatal and neonatal physiology have provided the basis for
improved outcomes for preterm and other infants with disorders causing respiratory failure …

Evaluación de la enfermedad de membrana hialina en recien nacidos

JA Perna, I Pérez, JE Ramírez… - Revista Repertorio de …, 2002 - revistas.fucsalud.edu.co
Para valorar la incidencia de la enfermedad de membrana hialina (EMH), caracterizar la
población de riesgo, evaluar el tratamiento instaurado y las complicaciones más frecuentes …

Development of gene correction and supplementation therapy based on chemical modification and sequence optimized mRNA for monogenetic diseases

AKM Haque - 2020 - tobias-lib.ub.uni-tuebingen.de
Gene therapy has been considered as a viable therapeutic option for life limiting genetic
diseases (eg Cystic Fibrosis (CF) and ß-Thalassemia) lacking conventional therapy. Over …

Kongenitale Alveolarproteinose Hereditärer Mangel an Surfactant-Protein B: Hereditärer Mangel an Surfactant-Protein B

B Bohnhorst, M Stuhrmann, LM Nogee… - Monatsschrift …, 1996 - Springer
Wir berichten über ein reifes weibliches Neugeborenes mit unauffälliger Familienanamnese,
das wenige Stunden postpartal mit einer Tachydyspnoe und zunehmender Zyanose …

Surfactant protein d family: potential for diagnosis or monitoring therapy in autoimmune diseases?

RI Fox, C Fox - The Journal of Rheumatology, 2015 - jrheum.org
In this issue of The Journal, Soto-Cárdenas, et al examine the frequency of a genetic
polymorphism that is associated with elevated surfactant protein D (SP-D) levels and assess …